COMPASS THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-32.8K | $-32.2M | $466.0K | $915.0K |
| FY2020 | $-32.1K | $-26.9M | $106.0K | $4.0M |
| FY2021 | $-19.7M | $-21.2M | $1.6M | $4.0M |
| FY2022 | $-34.1M | $-34.3M | $212.0K | $5.3M |
| FY2023 | $-40.6M | $-40.6M | $30.0K | $6.1M |
| FY2024 | $-44.9M | $-44.9M | $44.0K | $8.6M |
| FY2025 | $-49.1M | $-49.2M | $25.0K | $8.4M |